View drug registration information details.
Items | Registration information |
ID | 2038 |
No | 2038 |
Brand Name | CEFO - L 200 MG |
Ingredients | CEFIXIME TRIHYDRATE USP 228.48 MG EQ.TO CEFIXIME ANHYDROUS 200 MG, LACTIC ACID BACILLUS 60 MILLION SPORES 35 MG |
Dosage Form | TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | 10'S/BLISTER, 10 BLISTERS/BOX |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | RESPIRATORY TRACT INFECTIONS, OTITIS MEDIA, SEQUENTIAL TREATMENT AFTER INITIAL I.V. CHEMOTHERAPY AFTER PARENTERAL CEPHALOSPORIN, URINARY TRACT INFECTIONS, GONORRHOEA, TYPHOID FEVER |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | ORANGE COLORED, CIRCULAR, FLAT BEVELED EDGED, UNCOATED TABLET HAVING PLAIN SURFACE ON BOTH THE SIDES |
Note | |
License Owner | PALAMY PHARMA CO., LTD |
Manufacturer | MEDLEY PHARMACEUTICALS LTD. |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 07 I 3145/08 |
FDD Registration Date | 19-Apr-2023 |
Expiry Date | 18-Apr-2026 |
Back to drug list
|